Status:
TERMINATED
Brain Injury Self-Efficacy Scale Validation
Lead Sponsor:
Rehabilitation Hospital of Indiana
Conditions:
Traumatic Brain Injury
Self Efficacy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to validate the Brain Injury Self-Efficacy Scale as a measure of self-efficacy in brain injury by comparing it with other measures of self-efficacy, the GSE, and PROMIS se...
Detailed Description
Brain injury (BI) can be a devastating experience for many survivors, resulting in chronic difficulties in social, emotional, and physical functioning (Landau \& Hissett, 2008). Emotional and neurobeh...
Eligibility Criteria
Inclusion
- persons with a history of brain injury (e.g., Traumatic Brain Injury) or acquired BI such as stroke, hypoxia, ruptured aneurysm, or metabolic encephalopathy)
- age 18 and older
- able to speak English fluently.
Exclusion
- \- present with receptive/expressive aphasia preventing them from comprehending the questions or responding appropriately
Key Trial Info
Start Date :
April 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04371120
Start Date
April 1 2019
End Date
June 30 2023
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rehabilitation Hospital of Indiana
Indianapolis, Indiana, United States, 46268